Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration
Kao DP, Martin JL, Aquilante CL, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004343.
Leggi
Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials
de Vries ST, Pena MJ, Tye SC, et al.
Diabetologia. Pub. online 10 Dec 2024.
Leggi
Comparative risk of type 2 diabetes development between women with gestational diabetes and women with impaired glucose tolerance over two decades: a multiethnic prospective cohort in New Zealand
Yu D, Fu H, Zhao Z, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004210.
Leggi
Effect of flexor tendon tenotomy of the diabetic hammertoe on plantar pressure: a randomized controlled trial
Askø Andersen J, Rasmussen A, Engberg S, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004398.
Leggi
Intensive glucose lowering and its effects on vascular events and death according to age at diagnosis and duration of diabetes: the ADVANCE trial
Ohkuma T, Harris K, Woodward M, et al.
Diabetes Care. 2024:dc241516.
Leggi
The association between glycaemic variability and sleep quality and quantity in adults with type 1 and type 2 diabetes: a systematic review
Pham CT, Ali A, Churilov L, et al.
Diabet Med. 2024:e15485.
Leggi
Metformin treatment with or without mediterranean diet for the prevention of age-related diseases in people with metabolic syndrome: the MeMeMe randomized trial
Pasanisi P, Oliverio A, Baldassari I, et al.
Diabetes Care. 2024:dc241597.
Leggi
Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee
Diabetes Care. 2025;48(Supplement_1).
Leggi
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Moser O, Zaharieva DP, Adolfsson P, et al.
Diabetologia. Pub. online 10 Dec 2024.
Leggi
SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and/or obesity: a systematic review and network meta-analysis
Bao Y, Hu Y, Shi M, Zhao Z
Diabetes Obes Metab. Pub. online 6 Dec 2024.
Leggi